Erratum: Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study

Erratum: Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Oncology
Subjects:	PTLD Epstein - Barr virus allogeneic hematopoietic stem cell transplantation solid organ transplantation outcome
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1290218/full

Similar Items

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
by: Philipp Lückemeier, et al.
Published: (2023-06-01)

CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
by: Milan Košťál, et al.
Published: (2012-01-01)

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
by: Rabea Asleh, et al.
Published: (2022-02-01)

Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey
by: Alastair Baker, et al.
Published: (2021-07-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
by: Paibel Aguayo-Hiraldo, et al.
Published: (2016-01-01)

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression
by: Jean L. Koff, et al.
Published: (2024-01-01)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
by: Jennifer L. Crombie, et al.
Published: (2019-03-01)

Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation
by: Elodie Cheyssac, et al.
Published: (2023-01-01)

Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
by: Pascal Roland Enok Bonong, et al.
Published: (2021-03-01)

Epstein–Barr virus reactivation in pediatric allogeneic stem cell transplant recipients: an 11-year experience on viral load and B lymphocyte monitoring strategy
by: Giulia Ferrando, et al.
Published: (2024-10-01)

Viral Infections in HSCT Recipients with Post-Transplant Lymphoproliferative Disorder: The Role of Torque Teno Virus as a Marker of Immune Functions
by: Martyna Pociupany, et al.
Published: (2025-02-01)

Chronic Epstein-Barr viral load carriage after pediatric organ transplantation
by: Masaki Yamada, et al.
Published: (2024-01-01)

Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01)

The trend of Epstein-Barr virus DNA loads and CD8+ T lymphocyte numbers can predict the prognosis of pediatric liver transplant recipients with PTLD
by: Wang Kedi, et al.
Published: (2025-02-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
by: David M. Burns, et al.
Published: (2019-10-01)

Age and Epstein-Barr viral load at diagnosis of post-transplant lymphoproliferative disease are associated with patient survival in kidney transplant recipients
by: Diogo Francisco, et al.
Published: (2024-09-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome
by: Bixin Xi, et al.
Published: (2021-05-01)

Post-transplant lymphoproliferative disorder: Case reports of three children with kidney transplant
by: Spasojević-Dimitrijeva Brankica, et al.
Published: (2014-01-01)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
by: Rosanna Fulchiero, et al.
Published: (2022-12-01)

Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder
by: Ayantika Sen, et al.
Published: (2022-10-01)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
by: Tinelli Carmine, et al.
Published: (2011-09-01)

Incidence of Common Herpesviruses in Colonic Mucosal Biopsies Following Hematopoietic Stem Cell Transplantation
by: Oleg V. Goloshchapov, et al.
Published: (2022-10-01)

Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children
by: Agata Marjańska, et al.
Published: (2024-07-01)

Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis
by: Marjan Moghadamnia, et al.
Published: (2025-01-01)

Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation
by: Xin Kong, et al.
Published: (2024-10-01)

PD-1 Blockade Aggravates Epstein–Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations
by: Valery Volk, et al.
Published: (2021-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-03-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Mohammad Jahani, et al.
Published: (2011-01-01)

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD
by: Julien Lupo, et al.
Published: (2022-08-01)

Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria
by: Anna Füreder, et al.
Published: (2021-10-01)

Epstein-Barr Virus Encephalitis and Disseminated Adenovirus Infection after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for a Patient with Ph-Like Acute Lymphoblastic Leukemia
by: Xiao Zhou, et al.
Published: (2022-03-01)

Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial
by: Xin Xu, et al.
Published: (2022-09-01)

Navigating Epstein–Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance
by: Erin Y. Chen, et al.
Published: (2025-02-01)

Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation
by: Ling Zhou, et al.
Published: (2019-02-01)

Low incidence and morbidity of Epstein‐Barr virus reactivation following donor lymphocyte infusions
by: Danilo Martinovic, et al.
Published: (2023-05-01)

Successful Treatment of Relapsed Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis After Allo-HSCT with PD-1 Blockade: A Case Report
by: Pi Y, et al.
Published: (2022-07-01)